Table 1.
Clinical and serum biochemical parameters of subjects
| NAFLD (n = 112) |
Control (n = 112) |
P value | |
|---|---|---|---|
| Gender (M/F) | 68/44 | 62/50 | |
| Age | 46 ± 14 | 41 ± 15 | 0.538 |
| Height (cm) | 169.42 ± 8.73 | 170.59 ± 8.07 | 0.615 |
| Weight (kg) | 77.55 ± 13.49 | 62.37 ± 8.05 | 0.001** |
| BMI (kg/m2) | 27.1(24–28.55) | 21.46(20.57–22.54) | 0.001** |
| Systolic pressure (mmHg) | 125.41(120–130) | 123.59(115–132) | 0.375 |
| Diastolic pressure (mmHg) | 79.74(75–85) | 77.63(74–81) | 0.183 |
| Waist circumference (cm) | 91.75 ± 11.76 | 72.04 ± 5.96 | 0.001 |
| Heart rate (BPM) | 68.68 ± 5.09 | 68.80 ± 4.88 | 0.851 |
| Smoking (n) | 62 | 83 | 0.154 |
| Drinking (n) | 0.916 | ||
| None | 10 | 6 | |
| Light | 38 | 43 | |
| Moderate | 64 | 63 | |
| Blood glucose (mmol/L) | 5.12 ± 0.35 | 5.21 ± 0.42 | 0.38 |
| TB (umol/L) | 12.74 ± 2.54 | 12.89 ± 3.62 | 0.862 |
| DB (umol/L) | 2.32 ± 0.5 | 2.23 ± 0.95 | 0.669 |
| TP (g/L) | 73.52 ± 4.71 | 73.11 ± 5.4 | 0.769 |
| ALB (umol/L) | 41.85 ± 2.99 | 41.37 ± 5.46 | 0.689 |
| CHE (U/L) | 8400.78 ± 1353.66 | 7694.52 ± 1640.95 | 0.09 |
| ALT (U/L) | 20.67 ± 11.67 | 28.04 ± 19.13 | 0.093 |
| AST (U/L) | 23.93 ± 6.49 | 27.7 ± 13.02 | 0.183 |
| ALP (U/L) | 76.96 ± 18.08 | 84.33 ± 22.15 | 0.186 |
| γ-GT(U/L) | 23.74 ± 11.8 | 31.59 ± 22.75 | 0.118 |
| TC (mmol/L) | 5.67 ± 1.22 | 4.57 ± 0.8 | 0.001** |
| TG (mmol/L) | 0.83 ± 0.96 | 1.24 ± 0.56 | 0.008* |
| HDL-C (mmol/L) | 0.98 ± 0.18 | 1.49 ± 0.35 | 0.002* |
| LDL-C (mmol/L) | 4.89 ± 0.73 | 3.65 ± 1.01 | 0.002* |